01058nam a2200277 i 4500991001625559707536060511s it a b |01 e ita 8837032765b13401622-39ule_instBiblioteca Interfacoltà ita935.003Ascalone, Enrico592276Mesopotamia /Enrico AscaloneMilano :Electa,c2005367 p. :ill. ;cm 21I dizionari delle civiltà In cop.: Mesopotamia, assiri, sumeri e babilonesiInclude bibliografia e indiciMesopotamiaCiviltà .b1340162202-04-1411-05-06991001625559707536LE019 A21 AR C 4212019000024891le019-E19.00-l- 04240.i1432686328-11-06LE002 SB 930.003 DIZ12002000474711le002pE19.00-no 00000.i1423451811-05-06Mesopotamia1000959UNISALENTOle019le00228-04-06ma -itait 0201555oam 2200493 450 991071734630332120210913084843.0(CKB)1000000000217294(OCoLC)1257494117(EXLCZ)99100000000021729420210624d2000 ua 0engurbn|||||||||txtrdacontentcrdamediacrrdacarrierIntegrating new allies into NATO /[prepared by John J. Lis and Zachary Selden]Washington, D.C. :Congressional Budget Office,2000.1 online resource (xii, 25 pages, 1 unnumbered page) illustrationsCBO paper"October 2000.""Prepared by John J. Lis and Zachary Selden"--Preface.Includes bibliographical references.Integrating new allies into North Atlantic Treaty OrganizationFinancefastMembership requirementsfastMilitary readinessCostsfastFinance.Membership requirements.Military readinessCosts.Lis John J.1414110Selden Zachary A.United States.Congressional Budget Office,GPOGPOGPOOCLCOOCLCFOCLCQGPOBOOK9910717346303321Integrating new allies into NATO3512373UNINA03456nam 22010573a 450 991036775190332120250203235437.09783039216772303921677510.3390/books978-3-03921-677-2(CKB)4100000010106198(oapen)https://directory.doabooks.org/handle/20.500.12854/54599(ScCtBLL)11dc1b6a-e5e4-457d-b656-26a0e89e0cfb(OCoLC)1163804709(oapen)doab54599(EXLCZ)99410000001010619820250203i20192019 uu engurmn|---annantxtrdacontentcrdamediacrrdacarrierNew Lipid Lowering Therapies For Cardiovascular and Metabolic Diseases : Lessons From The Past and Future Challenges /Ahmed BakillahMDPI - Multidisciplinary Digital Publishing Institute2019Basel, Switzerland :MDPI,2019.1 electronic resource (116 p.)9783039216765 3039216767 This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies.Biology, life sciencesbicsscapolipoproteinlipidsrisk stratificationproprotein convertase subtilisin-kexin type 9 (PCSK9)vaspinsphingolipidsPCSK9ceramidesatrial fibrillationcircular RNASTEMIcholesterollipoproteinscardiovascular disease (CVD)coronary artery bypass graftingatherosclerosisstatinLDL subfractionsacute kidney injurydyslipidemiagene expressionNSTEMINAFLDhyperlipidemianonstatincholesteryl ester transfer proteinlow-density lipoprotein cholesterolanacetrapibHDLacute coronary syndromemiRNAcardiovascular riskpleiotropic actionsgeneticABCA1sdLDLcardiovascular diseaseproprotein convertase subtilisin/kexin type 9inclisiranreverse cholesterol transportsterolsmall interfering RNA (siRNA)RNA-binding proteinscardiovascular diseasesNASHlow-density lipoprotein-cholesterol (LDL-C)strokenutrigeneticstype 2 diabetesstatinssphingomyelinhepatic fibrosisdiabetesBiology, life sciencesBakillah Ahmed1287692ScCtBLLScCtBLLBOOK9910367751903321New Lipid Lowering Therapies For Cardiovascular and Metabolic Diseases4322787UNINA